The diagnosis and management of autosomal dominant polycystic kidney disease (ADPKD) in patients of color poses unique challenges. Patients of Black and Hispanic descent are disproportionately affected by conditions such as hypertension and diabetes, which can potentially mask an ADPKD diagnosis. Hypertension, which is prevalent among Black individuals, can confound the diagnosis of ADPKD, as